Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 6201 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6202 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6203 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6204 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6205 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 6206 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 6207 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6208 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 64 |
| 6209 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 64 |
| 6210 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 52 |
| 6211 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6212 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 6213 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 49 |
| 6214 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 6215 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 47 |
| 6216 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 53 |
| 6217 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6218 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 49 |
| 6219 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 69 |
| 6220 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 6221 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 54 |
| 6222 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 65 |
| 6223 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 6224 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 60 |
| 6225 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6226 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6227 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 73 |
| 6228 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6229 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6230 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6231 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6232 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 68 |
| 6233 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6234 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 6235 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 6236 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 6237 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 60 |
| 6238 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6239 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6240 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6241 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 6242 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6243 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6244 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6245 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 6246 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 69 |
| 6247 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6248 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 6249 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6250 | Apheresis | Allogeneic | Myelodysplastic Syndrome – Rcmd | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6251 | Apheresis | Allogeneic | Myelodysplastic Syndrome – Raeb | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6252 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 72 |
| 6253 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6254 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6255 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6256 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6257 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6258 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 6259 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6260 | Apheresis | Autologous | Neuroblastoma | Hematology | 2016 | Standard Therapy | Germany | 5 |
| 6261 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 45 |
| 6262 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 70 |
| 6263 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 43 |
| 6264 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 69 |
| 6265 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 28 |
| 6266 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 1 |
| 6267 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 30 |
| 6268 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 71 |
| 6269 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 58 |
| 6270 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 17 |
| 6271 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 59 |
| 6272 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 58 |
| 6273 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 55 |
| 6274 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 44 |
| 6275 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6276 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 6277 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6278 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 39 |
| 6279 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 6280 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 73 |
| 6281 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 27 |
| 6282 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 65 |
| 6283 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 6284 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6285 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6286 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6287 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 6288 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6289 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 51 |
| 6290 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6291 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 6292 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6293 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6294 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6295 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 6296 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6297 | Apheresis | Allogeneic | Refractory Anemia With Excess Blasts | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6298 | Apheresis | Allogeneic | Saa / Amyloidosis | Hematology | 2016 | Standard Therapy | Poland | 45 |
| 6299 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Germany | 28 |
| 6300 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 18 |